5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
Clinical trial NCT03366116 · RECRUITING
Trial details
- NCT number
- NCT03366116
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-05
- Primary completion
- 2026-09-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.